White Matter Changes in Schizophrenia: Evidence for Myelin-Related Dysfunction

Cited by (793)

Items 401–500 of 793

1. MR spectroscopic evaluation of N-acetylaspartate's T2 relaxation time and concentration corroborates white matter abnormalities in schizophrenia
   Nuran Tunc‐Skarka, Wolfgang Weber‐Fahr, Mareen Hoerst, Andreas Meyer‐Lindenberg, Mathias Zink, Gabriele Ende · 2009 · NeuroImage
2. Grey and white matter abnormalities are associated with impaired spatial working memory ability in first-episode schizophrenia
   Luca Cocchi, Mark Walterfang, Renée Testa, Stephen James Wood, Marc L. Seal, John Suckling, Tsutomu Takahashi, Tina Proffitt, Warrick J. Brewer, Christopher L. Adamson et al. · 2009 · Schizophrenia Research
3. Sphingolipid abnormalities in psychiatric disorders: a missing link in pathology?
   Sujatha Narayan · 2010 · Frontiers in bioscience
4. Possible Role of Glia in Cognitive Impairment in Schizophrenia
   Bernhard Mitterauer · 2011 · CNS Neuroscience & Therapeutics
5. Imaging Phenotypes and Genotypes in Schizophrenia
   Jessica A. Turner, Padhraic Smyth, Fabio M. Macciardi, James H. Fallon, James L. Kennedy, Steven G. Potkin · 2006 · Neuroinformatics
6. Neurological Disorders in Schizophrenia
   Arman Danielyan, Henry A. Nasrallah · 2009 · Psychiatric Clinics of North America
7. Microvessel length density, total length, and length per neuron in five subcortical regions in schizophrenia
   Paweł Kreczmański, Helmut Heinsen, Valentina Mantua, Fritz Woltersdorf, Thorsten Masson, Norbert Ulfig, Rainald Schmidt‐Kastner, Hubert Korr, Harry W.M. Steinbusch, Patrick R. Hof et al. · 2009 · Acta Neuropathologica
8. Myelin-Associated Glycoprotein Gene and Brain Morphometry in Schizophrenia
   Daniel Felsky, Aristotle N. Voineskos, Jason P. Lerch, Arash Nazeri, Sajid Ali Shaikh, Tarek K. Rajji, Benoit H. Mulsant, James L. Kennedy · 2012 · Frontiers in Psychiatry
9. Decreased Expression of Sprouty2 in the Dorsolateral Prefrontal Cortex in Schizophrenia and Bipolar Disorder: A Correlation with BDNF Expression
   Anilkumar Pillai · 2008 · PLoS ONE
10. Abnormal fatty acid composition in the frontopolar cortex of patients with affective disorders
    Yoshitaka Tatebayashi, Naomi Nihonmatsu-Kikuchi, Yoshitaka Hayashi, Xin Yu, Masaaki Soma, Kenji Ikeda · 2012 · Translational Psychiatry
11. Myelination deficit in a phencyclidine-induced neurodevelopmental model of schizophrenia
    Ruiguo Zhang, Jue He, Shenghua Zhu, Handi Zhang, Hongxing Wang, Abulimiti Adilijiang, Lynda Kong, Junhui Wang, Jiming Kong, Qingrong Tan et al. · 2012 · Brain Research
12. White matter integrity, language, and childhood onset schizophrenia
    Kristi A. Clark, Katherine L. Narr, Joseph O’Neill, Jennifer G. Levitt, Prabha Siddarth, Owen R. Phillips, Arthur W. Toga, Rochelle Caplan · 2012 · Schizophrenia Research
13. Association study of Nogo‐related genes with schizophrenia in a Japanese case–control sample
    Daisuke Jitoku, Eiji Hattori, Yoshimi Iwayama, Kazuo Yamada, Tomoko Toyota, Mitsuru Kikuchi, Motoko Maekawa, Toru Nishikawa, Takeo Yoshikawa · 2011 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
14. Supplementation of Antipsychotic Treatment with the Amino Acid Sarcosine Influences Proton Magnetic Resonance Spectroscopy Parameters in Left Frontal White Matter in Patients with Schizophrenia
    Dominik Strzelecki, Michał Tomasz Podgórski, Olga Kałużyńska, Oliwia Gawlik-Kotelnicka, Ludomir Stefańczyk, Magdalena Kotlicka‐Antczak, Agnieszka Gmitrowicz, Piotr Grzelak · 2015 · Nutrients
15. A family-based association study of the myelin-associated glycoprotein and 2′,3′-cyclic nucleotide 3′-phosphodiesterase genes with schizophrenia
    Aristotle N. Voineskos, Vincenzo De Luca, Natalie Bulgin, Quinton van Adrichem, Sajid Ali Shaikh, Donna J. Lang, William G. Honer, James L. Kennedy · 2008 · Psychiatric Genetics
16. Microstructural abnormalities of uncinate fasciculus as a function of impaired cognition in schizophrenia: A DTI study
    Sadhana Singh, Kavita Singh, Richa Trivedi, Satnam Goyal, Prabhjot Kaur, Namita Singh, Triptish Bhatia A, Smita Neelkanth Deshpande, Subash Khushu · 2016 · Journal of Biosciences
17. Brodmann area analysis of white matter anisotropy and age in schizophrenia
    Jason S. Schneiderman, Erin A. Hazlett, King-Wai Chu, Jane Zhang, Chelain R. Goodman, Randall E. Newmark, Yuliya Torosjan, Emily L. Canfield, Jonathan J. Entis, Vivian Mitropoulou et al. · 2011 · Schizophrenia Research
18. Serum S100B Protein is Specifically Related to White Matter Changes in Schizophrenia
    Berko Milleit, Stefan Smesny, Matthias Rothermundt, Christoph Preul, Matthias Leopold Schroeter, Christof von Eiff, Gerald D. Ponath, Christine Milleit, Heinrich Sauer, Christian Gaser B · 2016 · Frontiers in Cellular Neuroscience
19. Stereological assessment of the dorsal anterior cingulate cortex in schizophrenia: absence of changes in neuronal and glial densities
    Malin Höistad, Helmut Heinsen, Bridget A. Wicinski, Christoph Schmitz, P. R. Hof · 2012 · Neuropathology and Applied Neurobiology
20. Regional axonal abnormalities in first episode schizophrenia: Preliminary evidence based on high b-value diffusion-weighted imaging
    Avi Mendelsohn, Rael D. Strous, Maya Bleich‐Cohen, Yaniv Assaf, Talma Hendler · 2006 · Psychiatry Research Neuroimaging
21. Internal Capsule Size in Good-Outcome and Poor-Outcome Schizophrenia
    Adam M. Brickman, Monte S. Buchsbaum, Zlatin Ivanov, Joan C. Borod, Nancy S. Foldi, Eunice Hahn, Serge A. Mitelman, Erin A. Hazlett, Samantha Lincoln, Randall E. Newmark et al. · 2006 · Journal of Neuropsychiatry
22. Alteration of the pro-oxidant xanthine oxidase (XO) in the thalamus and occipital cortex of patients with schizophrenia
    Tanja Maria Michel, Abigail J. Sheldrick, Sybille Camara, Edna Grünblatt, Frank W. Schneider, Peter Franz Riederer · 2010 · The World Journal of Biological Psychiatry
23. Magnetic resonance imaging correlates of first-episode psychosis in young adult male patients: combined analysis of grey and white matter
    Anne Ruef, Logos Curtis, Guenael Moy, Séverine Bessero, Maryse Badan Bâ, François Lazeyras, Karl‐Olof Lövblad, Sven Haller, Alain Malafosse, Pantéleimon Giannakopoulos et al. · 2012 · Journal of Psychiatry and Neuroscience
24. A novel rare variant R292H in RTN4R affects growth cone formation and possibly contributes to schizophrenia susceptibility
    Hiroki Kimura, Yuki Fujita, Takeshi Kawabata, Kanako Ishizuka, C Wang, Yoshimi Iwayama, Yuko Okahisa, Itaru Kushima, Mako Morikawa, Yota Uno et al. · 2017 · Translational Psychiatry
25. Evidence of brain network aberration in healthy subjects with urban upbringing – A multimodal DTI and VBM study
    Sophia Lammeyer, Bruno Dietsche, Udo Dannlowski, Tilo T. J. Kircher, Axel Krug · 2019 · Schizophrenia Research
26. Striatal development involves a switch in gene expression networks, followed by a myelination event: Implications for neuropsychiatric disease
    Gabriela Novak, Theresa Fan, Brian F. O’Dowd, Susan R. George · 2012 · Synapse
27. Proteomics Tackling Schizophrenia as a Pathway Disorder
    Daniel Martins‐de‐Souza · 2012 · Schizophrenia Bulletin
28. Volumetric White Matter Abnormalities in First-Episode Schizophrenia: A Longitudinal, Tensor-Based Morphometry Study
    Whitford, Thomas J., Grieve, Stuart M., Farrow, Tom F.D., Gomes, Lavier, Brennan, John, Harris, Anthony W.F., Gordon, Evian, Williams, Leanne M. · 2007 · American Journal of Psychiatry
29. A schizophrenia risk gene, ZNF804A, is associated with brain white matter microstructure
    Toshikazu Ikuta, Bart D. Peters, Saurav Guha, Majnu John, Katherine H. Karlsgodt, Todd Lencz, Philip R. Szeszko, Anil K. Malhotra · 2014 · Schizophrenia Research
30. Reduced fractional anisotropy and axial diffusivity in white matter in 22q11.2 deletion syndrome: A pilot study
    Zora Kikinis, Takeshi Asami, Sylvain Bouix A, Christine T. Finn, Thomas Ballinger, Erica Tworog‐Dube, Raju Kucherlapati, Ron Kikinis, Martha Elizabeth Shenton, Marek R. Kubicki · 2012 · Schizophrenia Research
31. Lower functional connectivity of white matter during rest and working memory tasks is associated with cognitive impairments in schizophrenia
    Yurui Gao, Muwei Li, Anna Huang, Adam W. Anderson, Zhaohua Ding, Stephan Heckers, Neil D. Woodward, John C. Gore · 2021 · Schizophrenia Research
32. The role of white matter for the pathophysiology of schizophrenia
    Paolo Brambilla, Michele Tansella · 2007 · International Review of Psychiatry
33. Proteomics as a Tool for Understanding Schizophrenia
    Daniel Martins‐de‐Souza · 2011 · Clinical Psychopharmacology and Neuroscience
34. Subtelomeric 6p25 deletion/duplication: Report of a patient with new clinical findings and genotype–phenotype correlations
    Natália D. Linhares, Marta Svartman, Tatiane Cristina Rodrigues, Carla Rosenberg, Eugênia Ribeiro Valadares · 2015 · European Journal of Medical Genetics
35. Increased Density of Prohibitin-Immunoreactive Oligodendrocytes in the Dorsolateral Prefrontal White Matter of Subjects with Schizophrenia Suggests Extraneuronal Roles for the Protein in the Disease
    Hans‐Gert Bernstein, Karl‐Heinz Smalla, Diana Dürrschmidt, Gerburg Keilhoff, Henrik Dobrowolny, Johann Steiner, Andrea Schmitt, Michael R. Kreutz, Bernhard Bogerts · 2012 · NeuroMolecular Medicine
36. Genetic study of the myelin oligodendrocyte glycoprotein (MOG) gene in schizophrenia
    Gwyneth C. Zai, Nicole A. King, K. Wigg, Jillian M. Couto, Gregory W.H. Wong, William G. Honer, Cathy L. Barr, James L. Kennedy · 2004 · Genes Brain & Behavior
37. Iloperidone in the treatment of schizophrenia: an evidence-based review of its place in therapy
    F. Tonin, A. Wiens, F. Fernandez-llimos, R. Pontarolo · 2016 · Core Evidence
38. N‐acetylcysteine attenuates the cuprizone‐induced behavioral changes and oligodendrocyte loss in male C57BL/7 mice via its anti‐inflammation actions
    Lin Zhang, Shuqin Xu, Qingjun Huang, Haiyun Xu · 2017 · Journal of Neuroscience Research
39. Progressive neuroanatomical changes caused by Grin1 loss-of-function mutation
    Katheron Intson, Matthijs C. van Eede, Rehnuma Islam, Marija Milenkovic, Yuanye Yan, Ali Salahpour, R. Mark Henkelman, Amy J. Ramsey · 2019 · Neurobiology of Disease
40. Ethnicity-Dependent Effects of Schizophrenia Risk Variants of the OLIG2 Gene on OLIG2 Transcription and White Matter Integrity
    Hiroshi Komatsu, Hikaru Takeuchi, Yoshie Kikuchi, Chiaki Ono, Zhiqian Yu, Kunio Iizuka, Yuji Takano, Yoshihisa Kakuto, Shunichi Funakoshi, Takashi Ono et al. · 2020 · Schizophrenia Bulletin
41. Quetiapine Attenuates Schizophrenia-Like Behaviors and Demyelination in a MK-801–Induced Mouse Model of Schizophrenia
    Jue He, Qian Zu, Chunyan Wen, Qianqian Liu, Pan You, Xin‐Min Li, Wenqiang Wang · 2020 · Frontiers in Psychiatry
42. Selective Review of Neuroimaging Findings in Youth at Clinical High Risk for Psychosis: On the Path to Biomarkers for Conversion
    Justin K. Ellis, Elaine F. Walker, David R. Goldsmith · 2020 · Frontiers in Psychiatry
43. Characterising Phospholipids and Free Fatty Acids in Patients with Schizophrenia: A Case-Control Study
    Wang, Dongfang, Sun, Xiaoyu, Maziade, Michel, Mao, Wei, Zhang, Chuanbo, Wang, Jingyu, Cao, Bing · 2021 · The World Journal of Biological Psychiatry
44. Changes in kynurenine metabolites in the gray and white matter of the dorsolateral prefrontal cortex of individuals affected by schizophrenia
    Nico Antenucci, Giovanna D’Errico, Francesco Fazio, Ferdinando Nicoletti, Valeria Bruno, Giuseppe Battaglia · 2024 · Schizophrenia
45. The Immediate Early Gene Egr3 Is Required for Hippocampal Induction of Bdnf by Electroconvulsive Stimulation
    Kimberly T. Meyers, Ketan K. Marballi, Samuel J. Brunwasser, Briana Renda, Milad Charbel, Diano F. Marrone, Amelia L. Gallitano · 2018 · Frontiers in Behavioral Neuroscience
46. Increased prefrontal cortical cells positive for macrophage/microglial marker CD163 along blood vessels characterizes a neuropathology of neuroinflammatory schizophrenia
    Yunting Zhu, Maree J. Webster, Adam K. Walker, Paul T. Massa, Frank A. Middleton, Cynthia Shannon Weickert · 2023 · Brain Behavior and Immunity
47. Progenitor cell-based treatment of glial disease
    Steven A. Goldman · 2017 · Progress in brain research
48. Decreased expression of Fyn protein and disbalanced alternative splicing patterns in platelets from patients with schizophrenia
    Kotaro Hattori, Hiroshi Fukuzako, Tomo Hashiguchi, Shun Hamada, Yoji Murata, Tomoko Isosaka, Shigeki Yuasa, Takeshi Yagi · 2009 · Psychiatry Research
49. Neurobehavioral Aspects of Cerebral White Matter Disorders
    Christopher Mark Filley · 2005 · Psychiatric Clinics of North America
50. Neuropathology of Schizophrenia
    Harrison, Paul J., Lewis, David A., Kleinman, Joel E. · 2010 · Schizophrenia
51. The Fetal Origins of Adult Mental Illness
    Laura Bennet, Alistair Jan Gunn · 2007 · Springer eBooks
52. The Timing and Specificity of Prenatal Immune Risk Factors for Autism Modeled in the Mouse and Relevance to Schizophrenia
    Grainne Mary McAlonan, Qi Li, Charlton Cheung · 2010 · Neurosignals
53. The structural connectivity pathology of first-episode schizophrenia based on the cardinal symptom of auditory verbal hallucinations
    Yibin Xi, Fan Guo, Hua Li, Xiao Chang, Jinbo Sun, Yuanqiang Zhu, Wen-Ming Liu, Long‐Biao Cui, Gang Chen, Huaning Wang et al. · 2016 · Psychiatry Research Neuroimaging
54. No association between the genetic polymorphisms in the RTN4R gene and schizophrenia in the Chinese population
    J. Meng, Yongyong Shi, Xinzhi Zhao, Shunling Guo, H. Wang, Yonglan Zheng, Ruqi Tang, Guoxin Feng, N. Gu, H. Liu et al. · 2006 · Journal of Neural Transmission
55. CCL11 or Eotaxin-1: An Immune Marker for Ageing and Accelerated Ageing in Neuro-psychiatric Disorders
    Mariya Ivanovska, Zakee Abdi, Marianna Murdjeva, Danielle S. Macêdo, Annabel Maes, Michael H. J. Maes · 2020 · Preprints.org
56. Is Neuregulin 1 Involved in Determining Cerebral Volumes in Schizophrenia? Preliminary Results Showing a Decrease in Superior Temporal Gyrus Volume
    Sarah Tosato, Marcella Bellani, Chiara Bonetto, Mirella Ruggeri, Cinzia Perlini, Antonio Lasalvia, Veronica Marinelli, Gianluca Rambaldelli, Doriana Cristofalo, Mariaelena Bertani et al. · 2012 · Neuropsychobiology
57. Loss of Function Studies in Mice and Genetic Association Link Receptor Protein Tyrosine Phosphatase α to Schizophrenia
    Nagahide Takahashi, Karin Sandager Nielsen, Branko Aleksić, Steffen Petersen, Masashi Ikeda, Itaru Kushima, Nathalie Vacaresse, Hiroshi Ujike, Nakao Iwata, Véronique Dubreuil et al. · 2011 · Biological Psychiatry
58. Potassium channel gene associations with joint processing speed and white matter impairments in schizophrenia
    Heather A Bruce, Peter V Kochunov, Sara A. Paciga, Craig L Hyde, X. Chen, Xie Zhi, B. Zhang, Hualin Simon Xi, Patricio O’Donnell, Christopher D. Whelan et al. · 2017 · Genes Brain & Behavior
59. Using mouse transgenic and human stem cell technologies to model genetic mutations associated with schizophrenia and autism
    David St Clair, Mandy Johnstone · 2018 · Philosophical Transactions of the Royal Society B Biological Sciences
60. Abnormal white matter connections between medial frontal regions predict symptoms in patients with first episode schizophrenia
    Toshiyuki Ohtani, Sylvain Bouix A, Amanda E. Lyall, Taiga Hosokawa, Yukiko Saito, Eric D. Melonakos, Carl‐Fredrik Westin, Larry J. Seidman, Jill M. Goldstein, Raquelle I. Mesholam‐Gately et al. · 2015 · Cortex
61. Information processing speed mediates the relationship between white matter and general intelligence in schizophrenia
    Clara Alloza, Simon R. Cox, Barbara J. Duff, Scott I. K. Semple, Mark E. Bastin, Heather Clare Whalley, Stephen M. Lawrie · 2016 · Psychiatry Research Neuroimaging
62. In Vitro Differentiation of Bone Marrow Stromal Cells into Oligodendrocyte-like Cells Using Triiodothyronine as Inducer
    Gholam Reza Kaka, Taki Tiraihi, Alireza Azizzadeh Delshad, Jalil Arabkheradmand, Hadi Kazemi · 2011 · International Journal of Neuroscience
63. Convergent evidence of the contribution of TP53 genetic variation (Pro72Arg) to metabolic activity and white matter volume in the frontal lobe in schizophrenia patients
    Vicente Molina, Sergi Papiol, Javier Sanz, Araceli Rosa, Bárbara Arias, Mar Fatjó‐Vilas, Julia Calama, Ana I. Hernández, Joemir Bécker, Lourdes Fañanás · 2011 · NeuroImage
64. Overstimulation of NMDA Receptors Impairs Early Brain Development in vivo
    Tomomi Aida, Yoshimasa Ito, Yuko K. Takahashi, Kohichi Tanaka · 2012 · PLoS ONE
65. White Matter Abnormalities and Animal Models Examining a Putative Role of Altered White Matter in Schizophrenia
    Haiyun Xu, Xin‐Min Li · 2011 · Schizophrenia Research and Treatment
66. Long-Acting Injectable Second-Generation Antipsychotics Improve Negative Symptoms and Suicidal Ideation in Recent Diagnosed Schizophrenia Patients: A 1-Year Follow-up Pilot Study
    Valentina Corigliano, Anna Comparelli, Iginia Mancinelli, Benedetta Montalbani, Dorian A. Lamis, Antonella De Carolis, Denise Erbuto, Paolo Girardi, Maurizio Pompili · 2018 · Schizophrenia Research and Treatment
67. The bimodal mechanism of interaction between dopamine and mitochondria as reflected in Parkinson’s disease and in schizophrenia
    Dorit Ben‐Shachar · 2019 · Journal of Neural Transmission
68. The Current Challenges for Drug Discovery in CNS Remyelination
    Sonia Balestri, Alice Del Giovane, Carola Sposato, Marta Ferrarelli, Antonella Ragnini‐Wilson · 2021 · International Journal of Molecular Sciences
69. Redox Dysregulation in Schizophrenia: Genetic Susceptibility and Pathophysiological Mechanisms
    K. Q. Do, P. Bovet, Jan-Harry Cabungcal, P. Conus, René Gysin, S. Lavoie, P. Steullet, Michel Cuénod · 2009 · Springer eBooks
70. Paliperidone: the evidence of its therapeutic value in schizophrenia
    Joshua T. Kantrowitz · 2007 · Core evidence
71. Thiobarbituric acid reactive substances in the cerebrospinal fluid in schizophrenia
    Andrew O. Skinner, Sahebarao P. Mahadik, David L. Garver · 2004 · Schizophrenia Research
72. High b-value diffusion-weighted imaging: A sensitive method to reveal white matter differences in schizophrenia
    Philipp Sebastian Baumann, Leila Cammoun, Philippe Conus, Kim Q., Pierre P. Marquet, Djalel Eddine Meskaldji, Reto Antoine Meuli, Jean‐Philippe Thiran, Patric Hagmann · 2012 · Psychiatry Research Neuroimaging
73. Association between golli-MBP and schizophrenia in the Jewish Ashkenazi population: are regulatory regions involved?
    Kuti Baruch, Gilad Silberberg, Alex Aviv, Eyal Zvi Shamir, Ulli Bening-Abu-Shach, Yehuda Baruch, Ariel Darvasi, Ruth Navon · 2009 · The International Journal of Neuropsychopharmacology
74. Gray and white matter changes and their relation to illness trajectory in first episode psychosis
    Alejandro Keymer-Gausset, Anna Alonso-Solís, Iluminada Corripio, R.B. Sauras-Quetcuti, Edith Pomarol‐Clotet, Erick Jorge Canales-Rodríguez, Eva Grasa, Enric Álvarez, Marı́a J. Portella · 2018 · European Neuropsychopharmacology
75. Aberrant myelination of the cingulum and Schneiderian delusions in schizophrenia: a 7T magnetization transfer study
    Lena K. Palaniyappan, Ali Al‐Radaideh, Olivier E. Mougin, Tushar Das, Penny Anne Gowland, Peter Francis Liddle · 2018 · Psychological Medicine
76. Discoidin Domain Receptor 1, a Tyrosine Kinase Receptor, is Upregulated in an Experimental Model of Remyelination and During Oligodendrocyte Differentiation In Vitro
    Neus Franco‐Pons, Jordi Tomàs-Roig, Bárbara Roig, Carme Auladell, Lourdes Martorell, Elisabet Vilella · 2008 · Journal of Molecular Neuroscience
77. Polymorphisms of Transferrin gene are associated with schizophrenia in Chinese Han population
    Mei Qu, Weihua Yue, Fu‐Lei Tang, Lifang Wang, Yonghua Han, Dai Zhang · 2007 · Journal of Psychiatric Research
78. Prolonged Subdural Infusion of Kynurenic Acid Is Associated with Dose-Dependent Myelin Damage in the Rat Spinal Cord
    Wojciech Dąbrowski, Jacek M. Kwiecień, Radosław Rola, Michał Kłapeć, Greg J. Stanisz, Edyta Kotlińska-Hasiec, Wendy Oakden, Rafal Janik, Margaret Coote, Benicio Noronha Frey et al. · 2015 · PLoS ONE
79. A Classification of Sociomedical Health Indicators: Perspectives for Health Administrators and Health Planners
    Athilia E. Siegmann · 1976 · International Journal of Health Services
80. Diverse roles of mtDNA in schizophrenia: Implications in its pathophysiology and as biomarker for cognitive impairment
    Samuel Suárez-Méndez, Dulce Dajheanne García-de la Cruz, Carlos Alfonso Tovilla‐Zárate, Alma Delia Genis Mendoza, Rosa Angélica Ramón-Torres, Thelma Beatriz González‐Castro, Isela Esther Juárez‐Rojop · 2020 · Progress in Biophysics and Molecular Biology
81. Risk variant of oligodendrocyte lineage transcription factor 2 is associated with reduced white matter integrity
    Diana Pinto Prata, Richard Kanaan, Gareth J. Barker, Sukhwinder Singh Shergill, James Woolley, Lyudmila Georgieva, Marco Picchioni, Eugenia Kravariti, Muriel Walshe, Matthew P. G. Allin et al. · 2012 · Human Brain Mapping
82. Fast myelin water fraction estimation using 2D multislice CPMG
    Alireza Akhondi‐Asl, Onur Afacan, Mukund Balasubramanian, Robert V. Mulkern, Simon Keith Warfield · 2015 · Magnetic Resonance in Medicine
83. Association of SOX10 with schizophrenia in the Japanese population
    Nobuhisa Maeno, Nagahide Takahashi, Shinichi Saito, Xiaofei Ji, Ryoko Ishihara, Nagisa Aoyama, Branko Aleksić, Hideki Miura, Masashi Ikeda, Tatsuyo Suzuki et al. · 2007 · Psychiatric Genetics
84. Subchronic olanzapine exposure leads to increased expression of myelination-related genes in rat fronto-medial cortex
    Kari M. Ersland, Silje Skrede, C. T. Stansberg, Vidar Martin Steen · 2017 · Translational Psychiatry
85. Uncinate fasciculus white matter connectivity related to impaired social perception and cross-sectional and longitudinal symptoms in patients with schizophrenia spectrum psychosis
    Sra Jung, Ji Hye Kim, Gihye Sung, Young-gun Ko, Minji Bang, Chun Il Park, Sang‐Hyuk Lee · 2020 · Neuroscience Letters
86. Cellular and extracellular white matter alterations indicate conversion to psychosis among individuals at clinical high-risk for psychosis
    Felix Leonard Nägele, Ofer Pasternak, Lisa Bitzan, Marius Mußmann, Jonas Rauh, Marek R. Kubicki, Gregor Leicht, Martha Elizabeth Shenton, Amanda E. Lyall, Christoph Mulert · 2020 · The World Journal of Biological Psychiatry
87. Neuroanatomical changes in the adult rat brain after neonatal lesion of the medial prefrontal cortex
    Steffen Klein, Michael Koch, Kerstin Schwabe · 2007 · Experimental Neurology
88. Genetic contributions to changes of fiber tracts of ventral visual stream in 22q11.2 deletion syndrome
    Zora Kikinis, Nikos Makris, Christine T. Finn, Sylvain Bouix A, Diandra Lucia, Michael Coleman, Erica Tworog‐Dube, Ron Kikinis, Raju Kucherlapati, Martha Elizabeth Shenton et al. · 2013 · Brain Imaging and Behavior
89. Sluggishness of Early-Stage Face Processing (N170) Is Correlated with Negative and General Psychiatric Symptoms in Schizophrenia
    Yingjun Zheng, Haijing Li, Yuping Ning, Jianjuan Ren, Zhangying Wu, Rongcheng Huang, Guoming Luan, Tianfu Li, Taiyong Bi, Qian Wang et al. · 2016 · Frontiers in Human Neuroscience
90. Findings in Schizophrenia by Tract-Oriented DT-MRI Analysis
    Mahnaz Maddah, Marek R. Kubicki, William M. Wells, Carl‐Fredrik Westin, Martha Elizabeth Shenton, W. Eric L. Grimson · 2008 · Lecture notes in computer science
91. A family‐based and case‐control association study of SOX10 in schizophrenia
    Kazuya Iwamoto, Miki Bundo, Kazuo Yamada, Hitomi Takao, Yoshimi Iwayama, Takeo Yoshikawa, Tadafumi Kato · 2006 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
92. The relationship between TLR4/NF-κB/IL-1β signaling, cognitive impairment, and white-matter integrity in patients with stable chronic schizophrenia
    Hongna Li, Wenjin Chen, Mengzhuang Gou, Wei Li, Jinghui Tong, Yanfang Zhou, Ting Xie, Ting Yue Yu, Wei Feng, Yanli Li et al. · 2022 · Frontiers in Psychiatry
93. Accumulation of N-Acylphosphatidylserines and N-Acylserines in the Frontal Cortex in Schizophrenia
    Paul L. Wood · 2015 · Neurotransmitter
94. Laterality effects in schizophrenia and bipolar disorder
    Marcella Bellani, Carlo Alberto Marzi, Silvia Savazzi, Cinzia Perlini, Stefania Cerruti, Adele Ferro, Veronica Marinelli, Silvia Sponda, Gianluca Rambaldelli, Michele Tansella et al. · 2009 · Experimental Brain Research
95. Cognitive impairment in schizophrenia: profile, course, and neurobiological determinants
    Philip D. Harvey · 2012 · Handbook of clinical neurology
96. Regulation of oligodendrocyte differentiation: Insights and approaches for the management of neurodegenerative disease
    Abdullah Mohammad Tauheed, Joseph Olusegun Ayo, Mohammed Umaru Kawu · 2016 · Pathophysiology
97. Characterization of white matter abnormalities in early‐stage schizophrenia
    Tom A. Hummer, Michael Francis, Jenifer L. Vohs, Emily Liffick, Nicole F. Mehdiyoun, Alan F. Breier · 2016 · Early Intervention in Psychiatry
98. Nogo CAA 3′UTR Insertion polymorphism is not associated with Schizophrenia nor with bipolar disorder
    Sheila Passos Gregorio, Fábio Borges Mury, Elida P.B. Ojopi, Paulo Clemente Sallet, Doris Hupfeld Moreno, Juliana Yacubian, Hildeberto Tavares, Fabrício Rodrigues dos Santos, Wagner F. Gattaz, Emmanuel Dias‐Neto · 2005 · Schizophrenia Research
99. Anti-inflammatory effectiveness of topically administered corticosteroids in the cornea without epithelium.
    Allan Kupferman, Howard M. Leibowitz · 1975 · PubMed
100. Corpus callosum volumes in the 5 years following the first-episode of schizophrenia: Effects of antipsychotics, chronicity and maturation
     Mariana T.M. de Moura, Marcus V. Zanetti, Fábio Duran, Maristela S. Schaufelberger, Paulo Rossi Menezes, Márcia Scazufca, Geraldo F. Busatto, Maurício Henriques Serpa · 2018 · NeuroImage Clinical